Antiplatelet therapy: Aspirin, ticlopidine/clopidogrel, and anti- integrin agents

D. C. Calverley, G. J. Roth

    Research output: Contribution to journalArticle

    11 Scopus citations

    Abstract

    Aspirin is the most widely employed antithrombotic agent in use today and has a proven role in the prevention and acute management of atherosclerosis-associated arterial thrombotic events. More recently developed antiplatelet agents have been found to have specific prophylactic roles associated with percutaneous coronary intervention and other clinical settings. This article outlines pharmacologic considerations and current clinical knowledge relevant to the use of aspirin, ticlopidine, clopidogrel, and the GPIIbIIIa antagonists in the management of thrombotic disorders.

    Original languageEnglish (US)
    Pages (from-to)1231-1249
    Number of pages19
    JournalHematology/Oncology Clinics of North America
    Volume12
    Issue number6
    DOIs
    StatePublished - Jan 1 1998

      Fingerprint

    ASJC Scopus subject areas

    • Hematology
    • Oncology

    Cite this